These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

732 related items for PubMed ID: 18432277

  • 1. A canine minidystrophin is functional and therapeutic in mdx mice.
    Wang B, Li J, Qiao C, Chen C, Hu P, Zhu X, Zhou L, Bogan J, Kornegay J, Xiao X.
    Gene Ther; 2008 Aug; 15(15):1099-106. PubMed ID: 18432277
    [Abstract] [Full Text] [Related]

  • 2. [Adeno-associated virus vector carrying human minidystrophin gene SMCKA3999 effectively ameliorates dystrophic pathology in mdx model mice].
    Li HH, Zhang SM, Fang SY, Chen CL, Luo YD, Guan Y, Wang DW, Xiao X.
    Zhonghua Yi Xue Za Zhi; 2003 Sep 10; 83(17):1513-6. PubMed ID: 14521733
    [Abstract] [Full Text] [Related]

  • 3. Adeno-associated virus vector-mediated gene transfer into dystrophin-deficient skeletal muscles evokes enhanced immune response against the transgene product.
    Yuasa K, Sakamoto M, Miyagoe-Suzuki Y, Tanouchi A, Yamamoto H, Li J, Chamberlain JS, Xiao X, Takeda S.
    Gene Ther; 2002 Dec 10; 9(23):1576-88. PubMed ID: 12424610
    [Abstract] [Full Text] [Related]

  • 4. Restoration of all dystrophin protein interactions by functional domains in trans does not rescue dystrophy.
    Gardner KL, Kearney JA, Edwards JD, Rafael-Fortney JA.
    Gene Ther; 2006 May 10; 13(9):744-51. PubMed ID: 16307000
    [Abstract] [Full Text] [Related]

  • 5. Injection of a recombinant AAV serotype 2 into canine skeletal muscles evokes strong immune responses against transgene products.
    Yuasa K, Yoshimura M, Urasawa N, Ohshima S, Howell JM, Nakamura A, Hijikata T, Miyagoe-Suzuki Y, Takeda S.
    Gene Ther; 2007 Sep 10; 14(17):1249-60. PubMed ID: 17581597
    [Abstract] [Full Text] [Related]

  • 6. AAV vector-mediated microdystrophin expression in a relatively small percentage of mdx myofibers improved the mdx phenotype.
    Yoshimura M, Sakamoto M, Ikemoto M, Mochizuki Y, Yuasa K, Miyagoe-Suzuki Y, Takeda S.
    Mol Ther; 2004 Nov 10; 10(5):821-8. PubMed ID: 15509500
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Triple trans-splicing adeno-associated virus vectors capable of transferring the coding sequence for full-length dystrophin protein into dystrophic mice.
    Koo T, Popplewell L, Athanasopoulos T, Dickson G.
    Hum Gene Ther; 2014 Feb 10; 25(2):98-108. PubMed ID: 24191945
    [Abstract] [Full Text] [Related]

  • 11. Recombinant adeno-associated viral (rAAV) vectors as therapeutic tools for Duchenne muscular dystrophy (DMD).
    Athanasopoulos T, Graham IR, Foster H, Dickson G.
    Gene Ther; 2004 Oct 10; 11 Suppl 1():S109-21. PubMed ID: 15454965
    [Abstract] [Full Text] [Related]

  • 12. Long-term functional adeno-associated virus-microdystrophin expression in the dystrophic CXMDj dog.
    Koo T, Okada T, Athanasopoulos T, Foster H, Takeda S, Dickson G.
    J Gene Med; 2011 Sep 10; 13(9):497-506. PubMed ID: 22144143
    [Abstract] [Full Text] [Related]

  • 13. Adeno-associated virus vector-mediated minidystrophin gene therapy improves dystrophic muscle contractile function in mdx mice.
    Watchko J, O'Day T, Wang B, Zhou L, Tang Y, Li J, Xiao X.
    Hum Gene Ther; 2002 Aug 10; 13(12):1451-60. PubMed ID: 12215266
    [Abstract] [Full Text] [Related]

  • 14. [Current status and perspective of gene therapy on dystrophic animal model].
    Takeda S.
    Rinsho Shinkeigaku; 2004 Nov 10; 44(11):911-3. PubMed ID: 15651329
    [Abstract] [Full Text] [Related]

  • 15. Transient immunosuppression by FK506 permits a sustained high-level dystrophin expression after adenovirus-mediated dystrophin minigene transfer to skeletal muscles of adult dystrophic (mdx) mice.
    Lochmüller H, Petrof BJ, Pari G, Larochelle N, Dodelet V, Wang Q, Allen C, Prescott S, Massie B, Nalbantoglu J, Karpati G.
    Gene Ther; 1996 Aug 10; 3(8):706-16. PubMed ID: 8854096
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Expression of a NOS transgene in dystrophin-deficient muscle reduces muscle membrane damage without increasing the expression of membrane-associated cytoskeletal proteins.
    Tidball JG, Wehling-Henricks M.
    Mol Genet Metab; 2004 Aug 10; 82(4):312-20. PubMed ID: 15308129
    [Abstract] [Full Text] [Related]

  • 19. Stable transduction of myogenic cells with lentiviral vectors expressing a minidystrophin.
    Li S, Kimura E, Fall BM, Reyes M, Angello JC, Welikson R, Hauschka SD, Chamberlain JS.
    Gene Ther; 2005 Jul 10; 12(14):1099-108. PubMed ID: 15759015
    [Abstract] [Full Text] [Related]

  • 20. Efficient adenovirus-mediated transfer of a human minidystrophin gene to skeletal muscle of mdx mice.
    Ragot T, Vincent N, Chafey P, Vigne E, Gilgenkrantz H, Couton D, Cartaud J, Briand P, Kaplan JC, Perricaudet M.
    Nature; 1993 Feb 18; 361(6413):647-50. PubMed ID: 8437625
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 37.